118 related articles for article (PubMed ID: 32496457)
1. Central Nervous System Lymphoma: Approach to Diagnosis and Treatment.
Correia CE; Schaff LR; Grommes C
Cancer J; 2020; 26(3):241-252. PubMed ID: 32496457
[TBL] [Abstract][Full Text] [Related]
2. Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.
Heger JM; Mattlener J; Schneider J; Gödel P; Sieg N; Ullrich F; Lewis R; Bucaciuc-Mracica T; Schwarz RF; Rueß D; Ruge MI; Montesinos-Rongen M; Deckert M; Blau T; Kutsch N; Balke-Want H; Weiss J; Becker K; Reinhardt HC; Hallek M; Borchmann P; von Tresckow B; Borchmann S
Blood; 2024 Feb; 143(6):522-534. PubMed ID: 37946299
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma of the central nervous system originating from the septum pellucidum region: Two case reports with literature review.
Elendu C; Amaechi DC; Davidson G; Jingwa KA; Elendu TC
Medicine (Baltimore); 2024 Apr; 103(17):e37892. PubMed ID: 38669431
[TBL] [Abstract][Full Text] [Related]
4. Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas.
Lauer EM; Riegler E; Mutter JA; Alig SK; Bleul S; Kuehn J; Ranganathan L; Klingler C; Demerath T; Würtemberger U; Rau A; Weiß J; Eisenblaetter M; Bamberg F; Prinz M; Finke J; Duyster J; Illerhaus G; Diehn M; Alizadeh AA; Schorb E; Reinacher PC; Scherer F
Neuro Oncol; 2024 Feb; 26(2):374-386. PubMed ID: 37713267
[TBL] [Abstract][Full Text] [Related]
5. Perioperative Treatment in Muscle-invasive Bladder Cancer: Analysis of Secondary Endpoints in a Randomized Trial Comparing Gemcitabine and Cisplatin Versus Dose-dense Methotrexate, Vinblastine, Adriamycin, and Cisplatin.
Riaz IB; Hussain SA
Eur Urol; 2021 Feb; 79(2):222-224. PubMed ID: 33012577
[No Abstract] [Full Text] [Related]
6. Assessing changes in microstructural integrity of white matter tracts in children with leukaemia following exposure to chemotherapy.
Ramli N; Lim CH; Rajagopal R; Tan LK; Seow P; Ariffin H
Pediatr Radiol; 2020 Aug; 50(9):1277-1283. PubMed ID: 32591982
[TBL] [Abstract][Full Text] [Related]
7. Effect assessment of methotrexate in combination with other chemotherapeutic agents for osteosarcoma in children: A protocol for systematic review and meta-analysis.
Yan JP; Xiang RM
Medicine (Baltimore); 2021 May; 100(20):e25534. PubMed ID: 34011024
[TBL] [Abstract][Full Text] [Related]
8. A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates.
Kina S; Kawabata-Iwakawa R; Miyamoto S; Arasaki A; Sunakawa H; Kinjo T
J Drug Target; 2021 Dec; 29(10):1118-1127. PubMed ID: 33979258
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Melanoma Metastasis with ERBB2 Gene Amplification: A Potential for Future Targeted Therapy.
Gams P; Dolenc Stražar Z; Šoštarič M; Bošnjak M; Kšela J
Case Rep Oncol; 2021; 14(1):622-627. PubMed ID: 33976644
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of [
Krebs S; Mauguen A; Yildirim O; Hatzoglou V; Francis JH; Schaff LR; Mellinghoff IK; Schöder H; Grommes C
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3940-3950. PubMed ID: 33966087
[TBL] [Abstract][Full Text] [Related]
11. Long event-free survival after anti-BCMA CAR-T cell treatment for relapsed and refractory multiple myeloma patients: Two case reports.
Xu J; Ming X; Wang C; Xu B; Xiao Y
Medicine (Baltimore); 2021 May; 100(18):e25784. PubMed ID: 33950974
[TBL] [Abstract][Full Text] [Related]
12. Uracil-tegafur vs fluorouracil as postoperative adjuvant chemotherapy in Stage II and III colon cancer: A nationwide cohort study and meta-analysis.
Chen PH; Wu YY; Lee CH; Chung CH; Chen YG; Huang TC; Yeh RH; Chang PY; Dai MS; Lai SW; Ho CL; Chen JH; Chen YC; Hu JM; Yang SS; Chien WC
Medicine (Baltimore); 2021 May; 100(18):e25756. PubMed ID: 33950962
[TBL] [Abstract][Full Text] [Related]
13. The role of E255K/V-inclusive mutations in a Philadelphia-positive acute lymphoblastic leukemia with mutation evolution during sequential TKIs therapies: A case report.
Zhao M; Gui X; Wu Q; Xia L; Wang Y
Medicine (Baltimore); 2021 May; 100(18):e25579. PubMed ID: 33950935
[TBL] [Abstract][Full Text] [Related]
14. Treatment of pediatric alopecia areata: A systematic review.
Barton VR; Toussi A; Awasthi S; Kiuru M
J Am Acad Dermatol; 2022 Jun; 86(6):1318-1334. PubMed ID: 33940103
[TBL] [Abstract][Full Text] [Related]
15. Anesthetic technique and cancer surgery outcomes.
Dubowitz J; Hiller J; Riedel B
Curr Opin Anaesthesiol; 2021 Jun; 34(3):317-325. PubMed ID: 33935180
[TBL] [Abstract][Full Text] [Related]
16. Impact of Different JAK Inhibitors and Methotrexate on Lymphocyte Proliferation and DNA Damage.
Reddig A; Voss L; Guttek K; Roggenbuck D; Feist E; Reinhold D
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33916057
[TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system lymphoma: a narrative review of ongoing clinical trials and goals for future studies.
Schaff LR; Ambady P; Doolittle ND; Grommes C
Ann Lymphoma; 2021 Mar; 5():. PubMed ID: 33912868
[TBL] [Abstract][Full Text] [Related]
18. Global COVID-19 pandemic and reporting behavior - An analysis of the Food and Drug Administration adverse events reporting system.
Dörks M; Jobski K; Hoffmann F; Douros A
Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):707-715. PubMed ID: 33650210
[TBL] [Abstract][Full Text] [Related]
19. Central Nervous System Lymphomas.
Grommes C
Continuum (Minneap Minn); 2020 Dec; 26(6):1476-1494. PubMed ID: 33273169
[TBL] [Abstract][Full Text] [Related]
20. IAP Chemotherapy Regimen Is a Viable and Cost-effective Option in Children and Adolescents With Osteosarcoma: A Comparative Analysis With MAP Regimen on Toxicity and Survival.
Verma P; Jain S; Kapoor G; Tripathi R; Sharma P; Doval DC
J Pediatr Hematol Oncol; 2021 May; 43(4):e466-e471. PubMed ID: 32925402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
